However, our finding of not exhausted circulating TAA-specific CD8+ T-cell responses in a large cohort of HCC patients points towards the targeting of other antigens, such as neoantigens, that may drive T-cell exhaustion in natural HCC and may thus represent an optimal target of checkpoint inhibitor therapies. Here, CD8A is linked to hepatocellular carcinoma.